EP Biocomposites Limited (BOM:543595)
India · Delayed Price · Currency is INR 96.05
0.00 (0.00%)
At close: Aug 21, 2026
EP Biocomposites Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 162 | 141 | 207 | 231 | 339 | - | |
Market Cap Growth | -26.09% | -31.93% | -10.03% | -31.94% | - | - |
Enterprise Value | 164 | 169 | 230 | 224 | 329 | - |
Last Close Price | 96.05 | 84.00 | 123.40 | 137.15 | 201.50 | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 11.08 | 9.69 | 20.13 | 20.06 | 58.81 | - |
PS Ratio | 1.18 | 1.04 | 1.73 | 2.02 | 4.75 | - |
PB Ratio | 1.34 | 1.17 | 1.96 | 2.41 | 4.03 | - |
P/TBV Ratio | 1.34 | 1.17 | 1.97 | 2.43 | 4.09 | - |
P/FCF Ratio | 11.52 | 10.07 | - | - | - | - |
P/OCF Ratio | 8.12 | 7.10 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.20 | 1.24 | 1.92 | 1.96 | 4.61 | - |
EV/EBITDA Ratio | 6.89 | 7.12 | 12.39 | 13.71 | 30.68 | - |
EV/EBIT Ratio | 7.20 | 7.44 | 13.19 | 14.61 | 33.82 | - |
EV/FCF Ratio | 11.69 | 12.08 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.20 | 0.20 | 0.28 | 0.19 | 0.15 | 2.06 |
Debt / EBITDA Ratio | 1.01 | 1.01 | 1.60 | 1.10 | 1.20 | 2.97 |
Debt / FCF Ratio | 1.71 | 1.71 | - | - | - | - |
Net Debt / Equity Ratio | 0.02 | 0.02 | 0.13 | 0.06 | -0.11 | 1.98 |
Net Debt / EBITDA Ratio | 0.10 | 0.10 | 0.73 | 0.33 | -0.85 | 2.86 |
Net Debt / FCF Ratio | 0.17 | 0.17 | -2.66 | -0.36 | 1.12 | -0.83 |
Asset Turnover | 0.77 | 0.77 | 0.76 | 0.85 | 0.68 | 1.52 |
Inventory Turnover | 6.28 | 6.28 | 6.33 | 7.34 | 3.75 | 6.10 |
Quick Ratio | 2.97 | 2.97 | 3.49 | 2.37 | 3.87 | 1.48 |
Current Ratio | 3.34 | 3.34 | 3.95 | 2.84 | 4.45 | 1.73 |
Return on Equity (ROE) | 12.88% | 12.88% | 10.23% | 12.79% | 11.06% | 67.87% |
Return on Assets (ROA) | 8.05% | 8.05% | 6.88% | 7.15% | 5.79% | 15.53% |
Return on Invested Capital (ROIC) | 13.94% | 14.14% | 11.51% | 12.75% | 10.23% | 29.52% |
Return on Capital Employed (ROCE) | 16.20% | 16.20% | 13.40% | 14.40% | 10.10% | 30.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 9.03% | 10.32% | 4.97% | 4.98% | 1.70% | - |
FCF Yield | 8.68% | 9.93% | -2.46% | -6.42% | -2.41% | - |
Buyback Yield / Dilution | -0.03% | -0.03% | - | -15.13% | -71.17% | -127.55% |